lifestyle.pluralist.com

Author: OSR HOLDINGS CO., LTD.

Woori IO, an OSR Company, Signs NDA with Sinopharm for China Market and Global Multicenter Trials

March 19, 2026
Woori IO, an OSR Company, Highlights FDA Clarification on Non-Medical Wearables as a Catalyst for Accelerated Commercial Launch

January 23, 2026
Vaximm Appoints Sébastien Wieckowski, PhD, as Chief Scientific Officer to Advance Next-Generation Oral Immunotherapy Platform

January 16, 2026
Vaximm, an OSR Company, Receives Binding Term Sheet from BCM Europe for Global Exclusive License of VXM01 with $30M Upfront and Up to $815M in Milestones

January 12, 2026
Woori IO Shareholders Approve Share Exchange to Become Wholly-Owned Subsidiary of OSR Holdings

December 21, 2025
Vaximm AG, an OSR Company, Updates Term Sheet with BCM Europe to Shorten Exclusivity Period to Three Months

December 2, 2025
OSR Holdings to Present at the Emerging Growth Conference on December 10, 2025

December 1, 2025
OSR Holdings Appoints Scientific Co-Founder Dr. Andreas Niethammer as Chief Executive Officer of Vaximm AG to Lead Next Phase of Immuno-Oncology Expansion

November 18, 2025
OSR Holdings Announces Woori IO’s Noninvasive Glucose Monitor Demonstrates High Accuracy and Precision in Company-Sponsored Pilot Study

November 14, 2025